Description of amifostine administration among diverse sites participating in an observational registry

Authors :: JC Hill
R. Wang
C. P. Belani
J. Trotter
M. Kozloff
D. P. Miller
R. Sneeringer
R. Jagetia
H. H. Colwell
Source :: Journal of Clinical Oncology. 22:8182-8182
Publication Year :: 2004
Publisher :: American Society of Clinical Oncology (ASCO), 2004.
Abstract: 8182 Background: The Evaluating Cytoprotection Health Outcomes (ECHO) Registry, a prospective study of patients (pts) receiving amifostine prior to radiation and/or chemotherapy, collects both clin...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Chemotherapy
business.industry
medicine.medical_treatment
Amifostine
Health outcomes
Cytoprotection
carbohydrates (lipids)
Internal medicine
otorhinolaryngologic diseases
medicine
bacteria
Observational study
Prospective cohort study
business
medicine.drug

Full Text Access

Tools